Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. [electronic resource]
Producer: 20091026Description: 102-9 p. digitalISSN:- 1879-1220
- Carcinoma, Non-Small-Cell Lung -- enzymology
- Cell Line, Tumor
- Estrogen Receptor beta -- agonists
- Genistein -- pharmacology
- Ginsenosides -- pharmacology
- Humans
- Ligands
- Lung Neoplasms -- enzymology
- Mitogen-Activated Protein Kinase 1 -- genetics
- Nitriles -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Sapogenins -- pharmacology
- Transcription Factors -- genetics
- Transcription, Genetic
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.